Contextual Interference, Engagement , and Change in Motor Performance in Stroke
Associations Between Contextual Interference, Engagement During Treatment, and Change in Motor Performance Among Patients Posts-stroke
1 other identifier
interventional
50
1 country
1
Brief Summary
The aim of the study is to examine associations between contextual interference (CI), engagement during practice and changes in upper limb motor performance among patients post-stroke. Fifty patients over the age of 18, after a stroke, in the sub-acute and early chronic stages who have weakness of the upper extremity and are treated in a rehabilitation center will be recruited. The study will include participation in five sessions: session 1 for baseline assessment, session 2-4 for practice of upper extremity functions, and session 5 for post intervention assessment. The intervention will include training of three items from the Wolf motor function test in random order (high CI group) or block order (low CI group). Outcomes of engagement will include the brain engagement index, heart rate variability and galvanic skin response. Outcomes of learning will include the pre-post change in performance of the wolf motor function selected items.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_1
Started Jan 2020
Typical duration for phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2020
CompletedFirst Submitted
Initial submission to the registry
November 9, 2021
CompletedFirst Posted
Study publicly available on registry
April 25, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2023
CompletedApril 25, 2022
April 1, 2022
3 years
November 9, 2021
April 18, 2022
Conditions
Outcome Measures
Primary Outcomes (2)
Change in Brain Engagement Index
EEG activity in the prefrontal cortex will be measured by MindWave mobile EEG headset.
Practice session 1 (1-2 days following pre-intervention session), practice session 2 (1-2 days following practice session1), and practice session 3 (1-2 days following practice session1)
Change in time to complete each of three items of the Wolf Motor Function Test (WMFT)
A maximum of 120 seconds is allowed. Any performance that exceeds 120 seconds is assigned 120 seconds.
Pre-intervention session (first session), post-intervention session (session 5, 5-7 days following the pre-intervention session))
Secondary Outcomes (2)
Changes in Heart rate variability
Practice session 1 (1-2 days following pre-intervention session), practice session 2 (1-2 days following practice session1), and practice session 3 (1-2 days following practice session1)
Changes in Galvanic Skin Response (GSR)
Practice session 1 (1-2 days following pre-intervention session), practice session 2 (1-2 days following practice session1), and practice session 3 (1-2 days following practice session1)
Study Arms (2)
High contextual interference
EXPERIMENTALThe intervention will involve practicing three items from the Wolf motor function test in random order during three sessions. Each item will be repeated 30 times in total.
Low contextual interference
ACTIVE COMPARATORThe intervention will involve practicing three items from the Wolf motor function test in blocked order during three sessions. Each item will be repeated 30 times in total.
Interventions
The intervention will consist of training of items from the Wolf motor function test.
Eligibility Criteria
You may qualify if:
- Five days to 1-year post-stroke
- Score of 11-60 on the Fugl-Meyer Assessment for upper extremity
- The patient receives physical therapy and/or occupational therapy rehabilitation treatment
You may not qualify if:
- A history of neurological diseases other than stroke or orthopedics conditions that impair upper extremity function
- Pain that prevents active movement of the upper extremity
- Hemodynamic instability
- Cognitive decline and language difficulties that do not allow understanding of instructions and cooperation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Haifalead
- Reuth Rehabilitation Hospitalcollaborator
Study Sites (1)
Reut Medical Center
Tel Aviv, Israel
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Masking description: The outcome assessor will be blind to the group assignment of the participants. Participants and the investigator who deliver the intervention will be aware of group assignment because it is inherent to the type of practice they receive and deliver respectively.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
November 9, 2021
First Posted
April 25, 2022
Study Start
January 1, 2020
Primary Completion
January 1, 2023
Study Completion
June 1, 2023
Last Updated
April 25, 2022
Record last verified: 2022-04
Data Sharing
- IPD Sharing
- Will not share